Published in Rev Med Virol on May 17, 2016
Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses. J Infect Dis (2017) 0.75
Virucidal activity of WHO-recommended formulations against enveloped viruses including Zika, Ebola and emerging Coronaviruses. J Infect Dis (2017) 0.75
Immune protection against reinfection with nonprimate hepacivirus. Proc Natl Acad Sci U S A (2017) 0.75
Inactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugs. Sci Rep (2016) 0.75
Demonstration of disinfection procedure for the development of accurate blood glucose meters in accordance with ISO 15197:2013. PLoS One (2017) 0.75
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med (1998) 53.26
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet (2011) 6.21
Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR Recomm Rep (2001) 5.34
Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev (2009) 4.86
Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health (2001) 4.57
Hepatitis E. Lancet (2012) 4.43
Why don't physicians test for HIV? A review of the US literature. AIDS (2007) 3.80
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis (2014) 3.69
Hepatitis B virus infection. Lancet (2014) 2.78
Management of occupational exposures to blood-borne viruses. N Engl J Med (1995) 2.75
HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS (2012) 2.63
Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction (2010) 2.59
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang (2005) 2.47
Risk and management of blood-borne infections in health care workers. Clin Microbiol Rev (2000) 2.45
Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. J Infect Dis (1999) 2.34
Hepatitis E virus infection. Clin Microbiol Rev (2014) 2.21
HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS (2001) 2.08
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev (2011) 2.07
Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang (2012) 2.03
HIV and HCV infection among injecting drug users. Mt Sinai J Med (2000) 1.96
Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ (2013) 1.95
Mother-to-child transmission of HIV-1: timing and implications for prevention. Lancet Infect Dis (2006) 1.93
EASL recommendations on treatment of hepatitis C 2014. J Hepatol (2014) 1.81
Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review. Arch Pediatr Adolesc Med (2011) 1.76
Novel therapies for hepatitis C - one pill fits all? Nat Rev Drug Discov (2013) 1.43
Tears from children with chronic hepatitis B virus (HBV) infection are infectious vehicles of HBV transmission: experimental transmission of HBV by tears, using mice with chimeric human livers. J Infect Dis (2012) 1.43
Hepatitis B prevention, diagnosis, treatment and care: a review. Occup Med (Lond) (2011) 1.38
Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine (1999) 1.35
Efficacy of behavioral interventions to increase condom use and reduce sexually transmitted infections: a meta-analysis, 1991 to 2010. J Acquir Immune Defic Syndr (2011) 1.32
The worldwide impact of vaccination on the control and protection of viral hepatitis B. Dig Liver Dis (2011) 1.24
Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections. Hepatology (2015) 1.19
Blood-borne viruses in health care workers: prevention and management. J Clin Virol (2011) 1.18
Chronic hepatitis C virus infection in children. J Pediatr Gastroenterol Nutr (2010) 1.09
The impact of hepatitis E in the liver transplant setting. J Hepatol (2014) 1.06
Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis. Hepatology (2015) 1.05
Transmission of hepatitis C virus infection through tattooing and piercing: a critical review. Clin Infect Dis (2012) 1.04
Role of breast-feeding in transmission of hepatitis C virus to infants of HCV-infected mothers. J Hepatol (1998) 1.03
Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update. Clin Infect Dis (2012) 0.99
HIV-1 vaccine immunogen design strategies. Virol J (2015) 0.98
Interferons: Success in anti-viral immunotherapy. Cytokine Growth Factor Rev (2014) 0.98
When to start antiretroviral therapy: as soon as possible. BMC Med (2013) 0.95
A prophylactic hepatitis C virus vaccine: a distant peak still worth climbing. J Hepatol (2014) 0.95
Current status and prospects of HIV treatment. Curr Opin Virol (2016) 0.94
Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance. Viruses (2015) 0.92
Practical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection: an editorial review. AIDS (2014) 0.92
Novel HIV vaccine strategies: overview and perspective. Ther Adv Vaccines (2013) 0.90
Hepatitis E screening for blood donations: an urgent need? Lancet (2014) 0.90
The promise and pitfalls of long-acting injectable agents for HIV prevention. Curr Opin HIV AIDS (2016) 0.90
[S3 guideline hepatitis C addendum]. Z Gastroenterol (2015) 0.89
Progress towards a hepatitis C virus vaccine. Emerg Microbes Infect (2013) 0.87
Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis. BMC Infect Dis (2012) 0.87
Hepatitis B viral markers in banked human milk before and after Holder pasteurization. J Clin Virol (2009) 0.87
Hepatitis B virus reverse transcriptase - Target of current antiviral therapy and future drug development. Antiviral Res (2015) 0.85
Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons. HIV Med (2015) 0.85
Optimizing ART adherence: update for HIV treatment and prevention. Curr HIV/AIDS Rep (2014) 0.84
Strategies to manage hepatitis C virus infection disease burden - volume 3. J Viral Hepat (2015) 0.81
Antiviral therapy in chronic hepatitis E: a systematic review. J Viral Hepat (2015) 0.81
The undiagnosed chronically-infected HCV population in France. Implications for expanded testing recommendations in 2014. PLoS One (2015) 0.80
Primary Care of the Human Immunodeficiency Virus Patient. Med Clin North Am (2015) 0.78
Current status of immunomodulatory therapy in chronic hepatitis B, fifty years after discovery of the virus: Search for the "magic bullet" to kill cccDNA. Antiviral Res (2015) 0.78
The New Era of Interferon-Free Treatment of Chronic Hepatitis C. Viszeralmedizin (2015) 0.77
Raising awareness of viral hepatitis: National Hepatitis Testing Day, May 19. Public Health Rep (2012) 0.77
HIV: new drugs, new guidelines. Curr Opin Infect Dis (2014) 0.76
Cobicistat: Review of a Pharmacokinetic Enhancer for HIV Infection. Clin Ther (2015) 0.76
Opioid substitution therapy is associated with increased detection of hepatitis C virus infection: a 15-year observational cohort study. Drug Alcohol Depend (2015) 0.76